Karol Pál

823 total citations
19 papers, 152 citations indexed

About

Karol Pál is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Karol Pál has authored 19 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Karol Pál's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Karol Pál is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Karol Pál collaborates with scholars based in Czechia, Germany and Netherlands. Karol Pál's co-authors include Šárka Pospı́šilová, Lenka Radová, Michael Doubek, Jiřı́ Mayer, Nikola Tom, Jitka Malčíková, Veronika Navrkalová, Jana Kotašková, Karla Plevová and Andrea Janíková and has published in prestigious journals such as Blood, Bioinformatics and Frontiers in Immunology.

In The Last Decade

Karol Pál

19 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karol Pál Czechia 9 67 63 43 38 34 19 152
Ivelise Rijo United States 5 62 0.9× 38 0.6× 38 0.9× 45 1.2× 16 0.5× 7 126
Joel Wight Australia 8 104 1.6× 43 0.7× 21 0.5× 58 1.5× 15 0.4× 22 157
Takayasu Kato Japan 6 94 1.4× 44 0.7× 21 0.5× 45 1.2× 17 0.5× 25 159
Hein P. J. Visser Netherlands 5 71 1.1× 68 1.1× 25 0.6× 40 1.1× 25 0.7× 13 276
Pallavi Galera United States 6 51 0.8× 33 0.5× 19 0.4× 75 2.0× 55 1.6× 13 153
Jennifer A. Arzt United States 4 58 0.9× 65 1.0× 17 0.4× 52 1.4× 27 0.8× 5 151
Bevan Tandon United States 5 52 0.8× 56 0.9× 12 0.3× 22 0.6× 13 0.4× 6 131
Lauren Saguilig United States 7 69 1.0× 19 0.3× 39 0.9× 63 1.7× 16 0.5× 14 161
Barbara Mantoan Italy 7 106 1.6× 53 0.8× 31 0.7× 71 1.9× 11 0.3× 13 155
Chiara Lobetti Bodoni Italy 6 116 1.7× 105 1.7× 28 0.7× 67 1.8× 47 1.4× 8 194

Countries citing papers authored by Karol Pál

Since Specialization
Citations

This map shows the geographic impact of Karol Pál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Pál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Pál more than expected).

Fields of papers citing papers by Karol Pál

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karol Pál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Pál. The network helps show where Karol Pál may publish in the future.

Co-authorship network of co-authors of Karol Pál

This figure shows the co-authorship network connecting the top 25 collaborators of Karol Pál. A scholar is included among the top collaborators of Karol Pál based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karol Pál. Karol Pál is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jiang, Linmiao, Karol Pál, Peter J. Stewart, et al.. (2024). Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials. Leukemia. 38(12). 2675–2684. 4 indexed citations
2.
Szczepanowski, Monika, Michaela Kotrová, Nicola Gökbuget, et al.. (2023). Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications. Frontiers in Immunology. 14. 1125017–1125017. 3 indexed citations
3.
Plevová, Karla, Šárka Pavlová, Jitka Malčíková, et al.. (2022). Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. 22(1). 137–137. 3 indexed citations
4.
Genuardi, Elisa, Simone Ferrero, O. J. H. M. Verhagen, et al.. (2022). Genotyping and Minimal Residual Disease (MRD) Assessment in cfDNA By the Euroclonality-NGS DNA Capture (EC-NDC) Panel in Mantle Cell Lymphoma (MCL). Blood. 140(Supplement 1). 3518–3520. 1 indexed citations
5.
Szczepanowski, Monika, Michaela Kotrová, Nicola Gökbuget, et al.. (2022). IGH Rearrangement Evolution in Adult KMT2A-rearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring. HemaSphere. 7(1). e820–e820. 3 indexed citations
6.
Navrkalová, Veronika, Karla Plevová, Karol Pál, et al.. (2021). LYmphoid NeXt-Generation Sequencing (LYNX) Panel. Journal of Molecular Diagnostics. 23(8). 959–974. 14 indexed citations
7.
Malčíková, Jitka, Šárka Pavlová, Lenka Radová, et al.. (2021). Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 138(25). 2670–2685. 24 indexed citations
8.
Ljungström, Viktor, Andreas Agathangelidis, Ingrid L. M. Wolvers‐Tettero, et al.. (2021). Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia. Frontiers in Oncology. 11. 740083–740083. 4 indexed citations
9.
Navrkalová, Veronika, et al.. (2021). Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application. PeerJ. 9. e10897–e10897. 6 indexed citations
10.
Vozdová, Miluše, Svatava Kubı́čková, Karol Pál, et al.. (2020). Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing. Veterinary and Comparative Oncology. 18(4). 509–518. 10 indexed citations
11.
12.
Doubková, Martina, Kateřina Staňo Kozubík, Lenka Radová, et al.. (2019). A novel germline mutation of the SFTPA1 gene in familial interstitial pneumonia. Human Genome Variation. 6(1). 12–12. 18 indexed citations
13.
14.
Kotrová, Michaela, Karol Pál, Nikos Darzentas, et al.. (2019). PS942 CD19 MUTATION FREQUENCY AFTER BLINATUMOMAB TREATMENT IS LOWER THAN AFTER CAR T‐CELLS TREATMENT. HemaSphere. 3(S1). 424–425. 1 indexed citations
15.
Chitadze, Guranda, Anna Stengel, Heiko Trautmann, et al.. (2019). S129 TP53 SOMATIC MUTATIONS AS PRE‐LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA. HemaSphere. 3(S1). 16–17. 1 indexed citations
16.
Malčíková, Jitka, Nikola Tom, Karol Pál, et al.. (2019). ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. Leukemia & lymphoma. 60(6). 1420–1428. 20 indexed citations
17.
Hernández‐Sánchez, María, Jana Kotašková, Lenka Radová, et al.. (2018). CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase. Leukemia. 33(2). 518–558. 10 indexed citations
18.
Kozubík, Kateřina Staňo, Lenka Radová, Karol Pál, et al.. (2018). A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome. Platelets. 29(8). 827–833. 9 indexed citations
19.
Pál, Karol, Vojtěch Bystrý, Tomáš Reigl, et al.. (2017). GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data. Bioinformatics. 33(23). 3802–3804. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivelise Rijo Breakdown of academic impact, for papers by Joel Wight Breakdown of academic impact, for papers by Takayasu Kato Breakdown of academic impact, for papers by Hein P. J. Visser Breakdown of academic impact, for papers by Pallavi Galera Breakdown of academic impact, for papers by Jennifer A. Arzt Breakdown of academic impact, for papers by Bevan Tandon Breakdown of academic impact, for papers by Lauren Saguilig Breakdown of academic impact, for papers by Barbara Mantoan Breakdown of academic impact, for papers by Chiara Lobetti Bodoni
Rankless by CCL
2026